Fisher Asset Management’s Theriva Biologics TOVX Stock Holding History

Fisher Asset Management’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-503	Closed	-$6.78K	–	1121
2023 Q3	$6.78K	Hold	503	–	–	﹤0.01%	1108
2023 Q2	$12.6K	Hold	503	–	–	﹤0.01%	1094
2023 Q1	$8.78K	Hold	503	–	–	﹤0.01%	1059
2022 Q4	$6K	Hold	503	–	–	﹤0.01%	1024
2022 Q3	$12K	Hold	503	–	–	﹤0.01%	923
2022 Q2	$27K	Hold	503	–	–	﹤0.01%	892
2022 Q1	$36K	Hold	503	–	–	﹤0.01%	921
2021 Q4	$34K	Hold	503	–	–	﹤0.01%	947
2021 Q3	$58K	Hold	503	–	–	﹤0.01%	906
2021 Q2	$76K	Sell	503 -8	-2%	-$1.15K	﹤0.01%	902
2021 Q1	$87K	Buy	511 +8	+2%	+$1.58K	﹤0.01%	886
2020 Q4	$48K	Buy	503 +262	+109%	+$23K	﹤0.01%	899
2020 Q3	$29K	Hold	241	–	–	﹤0.01%	840
2020 Q2	$31K	Buy	+241	New	+$23K	﹤0.01%	800
2018 Q3	–	Sell	-15	Closed	-$32K	–	848
2018 Q2	$32K	Hold	15	–	–	﹤0.01%	796
2018 Q1	$43K	Hold	15	–	–	﹤0.01%	750
2017 Q4	$68K	Hold	15	–	–	﹤0.01%	855
2017 Q3	$125K	Hold	15	–	–	﹤0.01%	770
2017 Q2	$76K	Hold	15	–	–	﹤0.01%	738
2017 Q1	$84K	Hold	15	–	–	﹤0.01%	710
2016 Q4	$102K	Buy	15 +9	+150%	+$92.4K	﹤0.01%	711
2016 Q3	$86K	Buy	6 +3	+100%	+$44.9K	﹤0.01%	710
2016 Q2	$46K	Buy	3 +2	+200%	+$37.6K	﹤0.01%	687
2016 Q1	$29K	Hold	1	–	–	﹤0.01%	683
2015 Q4	$24K	Hold	1	–	–	﹤0.01%	732
2015 Q3	$24K	Buy	+1	New	+$24.6K	﹤0.01%	663

Other funds holding TOVX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fisher Asset Management's TOVX Position: Q4 2023 in Review

Fisher Asset Management sold out of Theriva Biologics (TOVX) in Q4 2023, closing a stake of 503 shares — an estimated $6.78K sold.

Fisher Asset Management first reported a position in TOVX in Q3 2015 and held it in 26 quarters. The position peaked at $125K in Q3 2017. 20 funds tracked by Wall St. Rank hold TOVX as of Q4 2023.

Fisher Asset Management reported no remaining Theriva Biologics position as of Q4 2023 after selling out during the quarter.
Fisher Asset Management sold 503 Theriva Biologics shares in Q4 2023, an estimated $6.78K.
Fisher Asset Management first reported a position in Theriva Biologics in Q3 2015 and held it in 26 quarters.
Fisher Asset Management's Theriva Biologics position peaked at $125K in Q3 2017.
20 funds tracked by Wall St. Rank held Theriva Biologics as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.